Financial News
Latest News about Squamous Cell Carcinoma
Recent news which mentions Squamous Cell Carcinoma
   OncoBeta reports 12-Month Results from International Phase IV Study for Non-Melanoma Skin Cancer
   
  
  August 13, 2025
  From PRLog
 
   Latest study demonstrates high efficacy in curing invasive non-melanoma skin cancer
   
  
  October 25, 2023
  From PRLog
 
   Fully recruited EPIC-Skin international study for the treatment of Non-Melanoma Skin Cancer
   
  July 11, 2023
  Tickers 
   EPIC
  
  
  From PRLog
 
   GenesisCare and OncoBeta announce partnership to provide innovative treatment for non-melanoma skin cancer
   
  
  May 17, 2023
  From PRLog
 
   Latest research shows Australians still not getting annual skin checks with a Health Professional
   
  
  March 01, 2023
  From PRLog
 
   South African skin cancer patients undergo first treatments with OncoBeta's Rhenium-SCT as part of the EPIC-Skin study
   
  
  December 22, 2022
  From PRLog
 
   'Spot Detective' – Check your spots this summer
   
  
  November 22, 2022
  From PRLog
 
   Perth skin cancer patients undergo first treatments with OncoBeta's Rhenium-SCT as part of the EPIC-Skin study
   
  
  June 15, 2022
  From PRLog
 From PRUnderground
 
   Sydney skin cancer patients join the EPIC-Skin study as they undergo first treatments with OncoBeta's Rhenium-SCT
   
  
  April 13, 2022
  From PRLog
 From PRLog
 
   EPIC-Skin study welcomes world-first skin cancer patients treated with OncoBeta's Rhenium-SCT
   
  
  March 10, 2022
  From PRLog
 
   First Patients Registered Into OncoBeta's International Registry For Non-Melanoma Skin Cancer Treatments
   
  
  February 14, 2022
  From PRLog
 
   OncoBeta receives ethics approval for EPIC-Skin study to evaluate Rhenium-SCT in Australia
   
  
  December 21, 2021
  From PRLog
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 

 
  
 
 
 










